Skip to search formSkip to main contentSkip to account menu

fluvastatin

Known as: 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate, fluindostatin, fluvastatin [Chemical/Ingredient] 
A synthetic lipid-lowering agent with antilipidemic and potential antineoplastic properties. Fluvastatin competitively inhibits hepatic 3-hydroxy-3… 
National Institutes of Health

Related topics

Related topics

19 relations
24 HR fluvastatin 80 MG Extended Release Oral Tablet24 HR fluvastatin 80 MG Extended Release Oral Tablet [Lescol]Coronary Artery DiseaseDrug Allergy

Broader (4)

Anticholesteremic AgentsFatty Acids, MonounsaturatedHydroxymethylglutaryl-CoA Reductase InhibitorsIndoles

Narrower (2)

LescolXU 62-320

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effects of Fluvastatin on Characteristics of Stellate Ganglion Neurons in a Rabbit Model of Myocardial Ischemia
Background: Stellate ganglion (SG) plays an important role in cardiovascular diseases. The electrical activity of SG neurons is… 
2015
2015
[The aggregation capacity of neutrophils in patients with arterial hypertension and dyslipidemia treated with fluvastatin].
AIM To elucidate the aggregation capacity of neutrophils in patients with arterial hypertension and dyslipidemia treated with… 
2009
2009
Lovastatin and fluvastatin reduce viremia and the pro-inflammatory cytokines in the patients with chronic hepatitis C.
BACKGROUNDS/AIMS Certain statins interfere with the mechanism of the hepatitis C virus replication. We aimed at studying the… 
2004
2004
Unrestricted Utilization of Sirolimus-Eluting Stents in the “Real World”: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry
markdownabstract__Abstract_ In-stent restenosis has long been considered the main limitation hampering the long-term efficacy… 
2003
2003
Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation
Background— The present studies were undertaken to investigate the potential effect of a hydroxymethylglutaryl coenzyme A… 
2003
2003
Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested.
With respect to antiplatelet therapy, randomized trials and their meta-analyses 1 indicate benefits of clopidogrel either as an… 
2001
2001
Effects of fluvastatin and its major metabolites on low-density lipoprotein oxidation and cholesterol esterification in macrophages.
We investigated effects of fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, and its major… 
1998
1998
Elderly patients with hypercholesterolaemia: a double‐blind study of the efficacy, safety and tolerability of fluvastatin
BackgroundCoronary heart disease is a major cause of morbidity and mortality in the elderly, a rapidly growing section of the… 
1995
1995
Metabolic Fate of Fluvastatin, an Inhibitor of HMG-CoA Reductase (1): Absorption, Distribution and Excretion of [14C]Fluvastatin after Single Administration in Rats
Fluvastatin (FV) is a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. Absorption… 
1994
1994
Development and pharmacology of fluvastatin.
: Fluvastatin is the first synthetic 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitor to be approved for…